BUSINESS REFLECTION: Cossed Wires: There is a nobler side to the AI hype
While AI’s risks dominate headlines, its quieter revolution in drug discovery is producing new treatments faster, including a promising therapy for fatal pulmonary fibrosis.
There is a brighter side to the AI hype, despite the overwhelming focus on its risks. In the past few weeks, numerous negative stories about AI have dominated the headlines, drowning out more positive developments. This has led to widespread anxiety over potential dystopian futures, causing people to overlook other aspects of AI's impact.
A recent conversation with Insilico Medicine, a company listed on the Hong Kong stock exchange, highlighted the potential benefits of AI in drug discovery. This groundbreaking company is leading the charge in an emerging industry that aims to create unprecedented treatments for various ailments using AI as its primary research partner.
Written by urgent.news from Daily Maverick's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
